Real-world outcomes by race in patients (pts) with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): Final analysis results from the informCLL registry.

被引：0
|
作者：
Barrientos, Jacqueline Claudia
Sharman, Jeff Porter
Gutierrez, Meghan E.
Wu, Linda
Qureshi, Zaina P.
Raz, Anat
Girardi, Vincent
Naganuma, Maoko
Ghosh, Nilanjan
机构：
[1] Mt Sinai Comprehens Canc Ctr, Miami Beach, FL USA
[2] US Oncol Res, Willamette Valley Canc Inst & Res Ctr, Eugene, OR USA
[3] Lymphoma Res Fdn, New York, NY USA
[4] Janssen, Horsham, PA USA
[5] Janssen Sci Affairs LLC, Horsham, PA USA
[6] Pharmacyclics LLC, San Francisco, CA USA
[7] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7536
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-World Outcomes with First-Line Ibrutinib (Ibr) Versus Chemoimmunotherapy (CIT) in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Final Analysis Results from the InformCLL Registry
    Ghosh, Nilanjan
    Sharman, Jeff P.
    Barrientos, Jacqueline C.
    Brander, Danielle
    Gutierrez, Meghan
    Wu, Linda
    Qureshi, Zaina P.
    Upasani, Sandhya
    Naganuma, Maoko
    Mato, Anthony R.
    BLOOD, 2022, 140 : 7047 - 7049
  • [2] Real-World Prognostic Biomarker Testing, Treatment Patterns and Dosing Among 1461 Patients (pts) with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) from the informCLL Prospective Observational Registry
    Mato, Anthony R.
    Barrientos, Jacqueline C.
    Sharman, Jeff P.
    Brander, Danielle M.
    Gutierrez, Meghan
    Kadish, Karen
    Arango-Hisijara, Israel
    Upasani, Sandhya
    Han, Jennifer
    Huang, Qing
    Iyengar, Reethi
    Ghosh, Nilanjan
    BLOOD, 2020, 136
  • [3] Real-World Treatment Patterns and Outcomes by Line of Therapy and Race in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated in the United States: Results From the Final Analysis of the Prospective, Observational, informCLL Registry
    Ghosh, Nilanjan
    Sharman, Jeff P.
    Gutierrez, Meghan
    Khan, Wasiulla
    Qureshi, Zaina P.
    Raz, Anat
    Girardi, Vincent
    Krigsfeld, Gabriel S.
    Barrientos, Jacqueline C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (09): : e301 - e313
  • [4] Insights From the informCLL Registry: Real-World Application of NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
    Ghosh, Nilanjan
    Brander, Danielle
    Mato, Anthony R.
    Sharman, Jeff P.
    Gutierrez, Meghan
    Naganuma, Maoko
    Upasani, Sandhya
    Alagappan, Divi
    Huang, Qing
    Young, Alex
    Barrientos, Jacqueline C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S317 - S317
  • [5] Real-world treatment patterns and outcomes of zanubrutinib in chronic lymphocytic leukemia and small lymphocytic leukemia (CLL/SLL)
    Krackeler, Margaret
    Chee, Bryant
    Orchanian, Arthur K.
    Law, Lisa Y.
    Lopez, Alfredo R.
    Buchanan, Susan
    Maglinte, Gregory A.
    Liu, Raymond
    Zhu, Zheng
    Sakoda, Lori C.
    Tavakoli, Jahan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Treatment sequencing and outcomes in patients with chronic lymphocytic leukemia: the informCLL™ real-world registry
    Mato, Anthony
    Ghosh, Nilanjan
    Barrientos, Jacqueline
    Brander, Danielle
    Pagel, John
    Gutierrez, Meghan
    Kadish, Karen
    Tomlinson, Brian
    Ipe, David
    Sundaram, Murali
    Han, Jennifer
    Amaya-Chanaga, Carlos
    Iyengar, Reethi
    Sharman, Jeff
    LEUKEMIA & LYMPHOMA, 2020, 61 : 33 - 36
  • [7] Real-world risk of bleeding events in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) treated with BTKi
    Moslehi, Javid J.
    Wahlstrom, Svea K.
    Teschemaker, Anna
    Mackey, Rachel H.
    DeVincenzo, Diana
    Carabuena, Leslie A.
    Thompson, Samantha L.
    Gordon, Brittaney
    Rosenthal, Ning A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Real-world characteristics and outcomes of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with long-term ibrutinib: results from the prospective, observational informCLL Registry
    Ghosh, Nilanjan
    Barrientos, Jacqueline
    Gutierrez, Meghan
    Qureshi, Zaina
    Khan, Wasiulla
    Raz, Anat
    Girardi, Vincent
    Krigsfeld, Gabriel
    Sharman, Jeff
    LEUKEMIA & LYMPHOMA, 2023, 64 : S61 - S62
  • [9] PATIENT-REPORTED OUTCOMES (PROS) FROM THE INFORMCLL REGISTRY: A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY OF US PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL)
    Sharman, J.
    Barrientos, J. C.
    Ghosh, N.
    Brander, D.
    Gutierrez, M.
    Wu, L.
    Panjabi, S.
    Upasani, S.
    Jermain, M.
    Naganuma, M.
    Mato, A.
    VALUE IN HEALTH, 2022, 25 (07) : S564 - S564
  • [10] Real-World Characterization of Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) Patients in British Columbia (BC)
    Khelifi, Rania S.
    Huang, Steven J. T.
    Savage, Kerry J.
    Villa, Diego
    Scott, David W.
    Ramadan, Khaled
    Connors, Joseph M.
    Sehn, Laurie H.
    Toze, Cynthia L.
    Gerrie, Alina S.
    BLOOD, 2020, 136
12345